Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
World
Kaamil Ahmed

Cost of tuberculosis treatment halved in deal to permit generic versions

Johnson & Johnson’s Sirturo, the branded version of bedaquiline.
Johnson & Johnson’s Sirturo, the branded version of bedaquiline. Photograph: Oksana Parafeniuk/Courtesy of MSF

The cost of a crucial tuberculosis treatment has been halved after an agreement was made to allow the sale of generic versions of the drug.

Johnson & Johnson’s price for bedaquiline, considered the backbone of treatment for drug-resistant TB will drop from $289 (£227) to $130 for a six-month course until December 2024.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.